Employment Law (Beecroft Report)

Debate between George Freeman and Mark Prisk

Monday 21st May 2012 Commons Chamber

[Mr Prisk]

Mr Speaker, I would test your patience if I were to list the full 10 elements of employment law as the hon. Gentleman requests, but he is right to say that that deal was struck under the current law. We do not live in a static world, however, and we need to ensure that we have examined all the changes in the workplace, whether in a large car plant or a small firm.

[George Freeman (Mid Norfolk) (Con)]

Does the Minister agree that, when the Government have decided how to respond to the report, it will be important to listen more to the small businessmen and women around the country than to those on the Labour Front Bench—I do not think that any of them have started a business—and to remember that micro-businesses are the key to the growth that we all want to see? Does he acknowledge that too many of our small companies are struggling with big-company legislation, and that well intentioned employment legislation often has the opposite effect, in that it puts employers off taking the risk of employing people and creates a licence for spurious claims at employment appeals tribunals?

[Mr Prisk]

My hon. Friend is absolutely right. We saw an unreformed employment tribunal system that—as my right hon. Friend the Secretary of State for Energy and Climate Change, who used to be an employment Minister, knows all too well—had failed under the last Government. This Government changed it, and that is a record we can be proud of.

Oral Answers to Questions

Debate between George Freeman and Mark Prisk

Thursday 31st March 2011 Commons Chamber

[George Freeman (Mid Norfolk) (Con)]

9. What steps he is taking to support the commercial development of life sciences through industry partnerships.

[The Minister of State, Department for Business, Innovation and Skills (Mr Mark Prisk)]

The Budget included a plan for growth for life sciences, including the development of a new technology innovation centre, the speeding up and reforming of clinical trials and the establishment of research partnerships to support the new model of open innovation and collaboration in the industry.

[George Freeman]

I thank the Minister for his reply and congratulate him on his commitment to business. Last week’s Budget set out a clear strategy for growth based on science, innovation and enterprise, particularly in my area, the biotech corridor between Cambridge and Norwich. Does he agree that the challenge is to ensure that our leading research institutes link up with industry so that our science is driven around the world in the three biggest markets: food, energy and medicine?

[Mr Prisk]

My hon. Friend is an outstanding champion in this field, and I was pleased that we were able to support Norwich research park in that context, for which he has fought and argued for many months. Our plan is about accelerating innovation, investing in the way collaboration takes place and ensuring that we retain this country’s world-class role in life sciences and biotechnology.

Oral Answers to Questions

Debate between George Freeman and Mark Prisk

Thursday 18th November 2010 Commons Chamber

[Mr Prisk]

I agree with my hon. Friend. Let me make it very clear again that when right hon. and hon. Members find unreasonable behaviour from the banks, they should ensure that it is raised with them and they should copy me in. When we find that evidence, we will challenge the banks vigorously.

[George Freeman (Mid Norfolk) (Con)]

As I know the Minister is aware, the highest of the high-technology growth businesses tend to rely for their early-stage finance not on banks but on early-stage investors, angels and family. Will he agree to make representations to the Treasury to look at anything we can do to incentivise such sources of finance?

[Mr Prisk]

I and my Treasury colleagues are already looking at how to improve business angel finance, not least at how the enterprise investment scheme works. We are also looking to extend a further £200 million in equity funds to the capital enterprise fund.